4Ds Memory Limited

4DS

4DS Memory Ltd. operates as a semiconductor development company. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-09. The firm is engaged in the development of a non-volatile memory technology known as Interface Switching resistive random-access memory (ReRAM), for gigabyte storage class memory. Interface Switching ReRAM, an area-based ReRAM technology positioned for storage class memory in mobile devices and cloud data centers. The company owns a patented Internet protocol (IP) portfolio, comprising 32 United States patents granted and an additional one patent application, which have been developed in-house to create high-density storage class memory. In collaboration with imec in Belgium, the Company is developing a production-compatible process for the 300-millimeter production tools that memory makers use to fabricate high-density, high-volume memories to use in a production-compatible process to build a 4DS megabit memory.

Aeon Metals Limited

AML

Aeon Metals Ltd. engages in the exploration of copper and molybdenum properties. The company is headquartered in Gold Coast, Queensland. The company went IPO on 2007-06-14. The firm holds a 100% ownership interest in the Walford Creek Copper-Cobalt Project (Walford Creek Project), which is located in north-west Queensland, approximately 340 kilometers (km) to the north north-west of Mt Isa. The firm also has interests in various exploration permits in Northwest Queensland. This tenement package covers approximately 1,441 square kilometers (km2), and located in the Mount Isa minerals province in northwest Queensland. The Southeast Queensland tenement package lies approximately 30 km west of the town of Monto, Queensland. These permits extend over a distance of approximately 500 km from north to south and are subdivided into four main project areas, Constance Range, Isa North, Isa West and Isa South. The company includes contiguous land holding, approximately 170 km, along the Mt Isa Fault, bordering north and south of Glencore Xstrata’s Mount Isa Mines.

Brainchip Holdings Ltd

BRN

BrainChip Holdings Ltd. engages in the development of software and hardware solutions for artificial intelligence and machine learning applications. The company is headquartered in Sydney, New South Wales and currently employs 66 full-time employees. The company went IPO on 2011-11-09. The principal activity of the Company is the development of software and hardware accelerated solutions for advanced artificial intelligence (AI) and machine learning applications with a primary focus on the development of its Neuromorphic Processor IP, Akida, to provide a complete ultra-low power and fast AI Edge network for vision, audio, olfactory and smart transducer applications. Its products include MetaTF, Akida1000 reference chip and Akida Enablement Platforms. The MetaTF development environment is a machine learning framework used for the creation, training, and testing of neural networks, supporting the development of systems for Edge AI on its Akida event domain neural processor. The Akida1000 reference chip is fully functional and enables working system evaluation. Its Akida Enablement Platforms include Akida PCIe Board, Akida Development Kit Shuttle PC and Akida Development Kit Raspberry Pi.

Carbonxt Group Limited

CG1

Carbonxt Group Ltd. manufactures and markets carbon products and hydrocarbon-based fuel. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-01-23. The firm is engaged in the development and sale of specialized Activated Carbon (AC) products, including Powdered Activated Carbon (PAC) and AC pellets for the removal of pollutants and toxins in industrial processes. Its products are used in industrial air purification, wastewater treatment and other liquid and gas phase markets, primarily for the capture of mercury and sulfur in order to reduce harmful emissions into the atmosphere. Its products include MATS-PAC, MATS-PACK S, CXT-WETJECT, CXT-NAQ-ACP, CEM-PAC, CEM-PAC-S, MACT-PAC, CXT-BB500, CXT-BB600, CXT-BB800, CXT-BB+, CXT-ACP60V, CXT-ACP50V, CXT-ACP45V, CXT-AQP50 and HYDRESTOR. The Company’s products application includes nutrient recovery technology, coal-fired power plants, cement plants, waste to energy: industrial boilers and incinerators, potable water, and volatile organic compounds (VOC) and contaminant removal.

Noxopharm Limited

NOX

Noxopharm Ltd. engages in the research and development of drugs. The company is headquartered in Gordon, New South Wales. The company went IPO on 2016-08-09. The firm is engaged in the discovery and development of treatments for cancer and inflammation. The firm has three active drug development programs: its clinical drug candidate Veyonda, plus two technology platforms, Chroma (oncology) and Sofra (inflammation and autoimmunity), which provide the basis for the active development of a growing pipeline of drugs. Veyonda (Idronoxil) is an adjuvant therapy in chemotherapy and radiotherapy in the treatment of late-stage cancers. The Chroma drug candidates have bioactive properties, which it is exploring primarily in the anti-cancer space. Its Sofra platform is centered around short nucleic acid sequences called oligonucleotides, which can act on specific cell receptors to stop inflammation, which is a source of various debilitating and lethal diseases. The company is also conducting a dose escalation and dose expansion study of NOX66 in the treatment of COVID-19 infection.